We are live on
!
Find out more
Protagonist Therapeutics
PTGX
PTGX
136.28
USD
-2.21
1.6%
At close
Updated
Oct 14, 4:00 PM EDT
Pre-market
After hours
136.28
0.00
0%
1 day
-1.6%
5 days
-2.36%
1 month
-7.78%
3 months
3.82%
6 months
30.14%
Year to date
56.32%
1 year
77.13%
5 years
336.93%
10 years
535.04%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 151 |
151
Engineers Gate Manager
New York
| – | -$90K | -11,383 | Closed |
|
| 152 |
QT
152
Quantamental Technologies
White Plains,
New York
| – | -$88K | -11,170 | Closed |
|
| 153 |
CC
153
Corton Capital
Carrying Place,
Ontario, Canada
| – | -$86K | -10,836 | Closed |
|
| 154 |
AI
154
Atom Investors
Austin,
Texas
| – | -$82K | -10,338 | Closed |
|
| 155 |
EBA
155
Eagle Bay Advisors
New York
| – | -$7.91K | -1,000 | Closed |
|
| 156 |
IBT
156
International Biotechnology Trust
London,
United Kingdom
| – | -$16.2K | -128 | Closed |
|
| 157 |
157
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -28 | Closed |
|